Common Contracts
2 similar Co-Development and Licensing Agreement contracts
Amendment to co-development and licensing agreement for naproxen and esomeprazole combination for painCo-Development and Licensing Agreement • June 2nd, 2021
This letter sets forth the understanding between POZEN INC. (“POZEN”) and Astrazeneca AB (“Astrazeneca”) with regard to the matters set forth below and in connection with the Collaboration Agreement. Any capitalized terms not otherwise defined herein shall have the meaning given such term in the Collaboration Agreement. POZEN and Astrazeneca herein are collectively referred to as the Parties.
Amendment to co-development and licensing agreement for naproxen and esomeprazole combination for painCo-Development and Licensing Agreement • June 2nd, 2021
This letter sets forth the understanding between POZEN INC. (“POZEN”) and Astrazeneca AB (“Astrazeneca”) with regard to the matters set forth below and in connection with the Collaboration Agreement. Any capitalized terms not otherwise defined herein shall have the meaning given such term in the Collaboration Agreement. POZEN and Astrazeneca herein are collectively referred to as the Parties.
